The Marshall University Office of Research Integrity (ORI) supports the institution in promoting ethical conduct of research and ensures the university’s solid commitment to compliance with all applicable regulations and accreditation standards. Marshall has an established Federal Wide Assurance (FWA #00002704) with the Office of Human Research Protections (OHRP).
The office currently provides support for both a Medical (IRB#1) and a Behavioral and Social Sciences (IRB#2) Institutional Review Board, the Institutional Animal Care and Use Committee (IACUC), and the Conflict of Interest in Research Committee.
ORI also supports the institution in promoting ethical conduct of research and educating Marshall students and employees regarding research misconduct regulations.
Copies of application forms, deadlines, information about policies and procedures, and Marshall University’s Statements of Assurance can be obtained on this website or by contacting ORI.
Applications for medical/biological research should be submitted to IRB #1. Applications for studies that have been approved under the National Cancer Institutes Central IRB should be submitted to the MU CIRB (under IRB#1).
The Marshall University Medical IRB (IRB#1) and Standard Operating Procedures SOP operate in accord with ICH-GCP guidelines only to the extent that they are compatible with FDA and DHHS regulations. GCP standards contained in the ICH document are not regulatory requirements in the United States and vary from FDA and DHHS regulations. As such, the MU IRB#1 and SOP do not voluntarily agree to comply with all of the GCP statements. Although the MU IRB#1 and SOP have not adopted the ICH-GCP guidelines in their entirety, they are in accordance with ICH-GCP guidelines regarding Institutional Review Board/Independent Ethics Committee (IRB/IEC) criteria 3.1 through 3.4 of E-6.
For clinical trials conducted in the United States, the MU IRB#1 is established, constituted and operated in agreement with the requirements of the Combined Federal Regulations 21 CFR 50 and 56.
Please submit the application package and the protocol to the IRB for review using our online submission system IRBNet.